Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

Do stress and depression increase the risk of Alzheimer's disease? Here's why there might be a link

Dementia affects more than 55 million people around the world. A number of factors can increase a person’s risk of developing dementia, including high blood pressure, poor sleep, and physical inactivity. Meanwhile, keeping cognitively, physically, and socially active, and limiting alcohol consumption, can reduce the risk.

The Conversation

People with early Alzheimer’s disease ‘have difficulty turning when walking’

It is hoped the findings will help secure earlier detection of the condition.

The Independent UK

Alzheimer's disease blood tests: here's what they look for, and what they can tell you about your risk

Despite affecting 55 million people worldwide, Alzheimer’s disease still has no cure. But recent advancements in the field have seen a number of promising drugs that can slow the disease’s progression pass late-stage clinical trials.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

As Ken Livingstone’s diagnosis is made public, what is Alzheimer’s?

On average, people with Alzheimer’s live for around eight to 10 years after first developing symptoms.

The Independent UK

Alzheimer's disease is partly genetic − studying the genes that delay decline in some may lead to treatments for all

Diseases that run in families usually have genetic causes. Some are genetic mutations that directly cause the disease if inherited. Others are risk genes that affect the body in a way that increases the chance someone will develop the disease. In Alzheimer’s disease, genetic mutations in any of three specific…

The Conversation

How many Americans have Alzheimer's disease and dementia?

As many as 6.7 million Americans over 65 have Alzheimer’s disease. That number is expected to more than double by 2060.

USAFacts

Black Angelenos Care for Alzheimer’s Patients — and Each Other

Support groups help manage the strain on caregivers in the epicenter of Alzheimer’s cases.

Capital & Main

Read news from The Economist, FT, and more,
with one subscription

People with Alzheimer’s disease tend to be deficient in these 5 nutrients that ‘help keep brains in top condition at all ages,’ researchers say

Not getting enough antioxidants can make your brain more frail and thinking more challenging, and contribute to the development of Alzheimer’s disease, researchers say.

Fortune

Scottish firm working towards ‘transformative’ early blood test for Alzheimer’s

Scottish Brain Sciences is collaborating with Roche Diagnostics on the project.

The Independent UK

These 10 U.S. states are predicted to have the most people with Alzheimer’s disease. Here’s why

Many are on the East Coast.

Fortune

Promising Vaccine Shows Potential To Reduce Alzheimer’s Impact

New research demonstrates vaccine's ability to eliminate toxic cells in mice, offering hope for treating dementia cases.

Zenger

New vaccine could be key to preventing Alzheimer’s disease, scientists say

‘If the vaccine could prove successful in humans, it would be a big step forward towards delaying disease progression’

The Independent UK

Study: Baltimore ranks among jurisdictions with highest Alzheimer’s disease prevalence

Baltimore has one of the highest rates of Alzheimer’s disease in the country and Maryland has the highest rate among states, according to an analysis published in the Alzheimer’s Association’s online journal.

Tribune News Service

Alzheimer's drug donanemab has been hailed as a 'turning point' for treatment. But what does it mean for people with the disease?

Trial results of a new drug to treat Alzheimer’s disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as a “turning point” in Alzheimer’s treatment.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Everything we know about breakthrough Alzheimer’s drug Donanemab

Alzheimer’s disease is the most common cause of dementia in the UK

Evening Standard

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

The Independent UK

‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

Donanemab has been found to slow down the disease in a clinical trial.

The Conversation

Young-onset Alzheimer’s can be diagnosed from as early as 30 – and the symptoms are often different

Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.

Salon

Sanders: Alzheimer's drug too expensive

"The high price of Leqembi threaten Medicare's finances, it will also negatively impact seniors on fixed incomes"

The Independent UK

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

Evening Standard

Fiona Phillips ‘hugely touched’ by support after revealing Alzheimer’s diagnosis

The former GMTV anchor announced she was diagnosed more than a year ago with the condition

Wales Online

Is Alzheimer's disease hereditary? What are your chances of getting Alzheimer's disease if your parents had it

There are certain gene changes that can increase your likelihood of getting the disease

Evening Standard

What are the symptoms of Alzheimer’s? New medication donanemab found to slow mental decline

Scientists believe that Alzheimer’s is triggered because of an abnormal build-up of proteins in the brain

1 … 3 4 5 6

People

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

Eli Lilly and Company

51 stories

the Alzheimer Society

37 stories

the Alzheimer Association

33 stories

Leqembi

23 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.